|
US 7,361,463 B2 |
|
Muteins of hypoxia inducible factor alpha and methods of use thereof |
William G. Kaelin, Jr., Boston, Mass. (US); and Mircea Ivan, Cambridge, Mass. (US) |
Assigned to Dana Farber Cancer Institute, Inc., Boston, Mass. (US) |
Filed on May 26, 2004, as Appl. No. 10/854,483. |
Application 10/854483 is a continuation of application No. 10/101816, filed on Mar. 19, 2002, granted, now 6,849,718. |
Claims priority of provisional application 60/345132, filed on Dec. 20, 2001. |
Claims priority of provisional application 60/342598, filed on Dec. 20, 2001. |
Claims priority of provisional application 60/345131, filed on Dec. 20, 2001. |
Claims priority of provisional application 60/345200, filed on Nov. 09, 2001. |
Claims priority of provisional application 60/332334, filed on Nov. 09, 2001. |
Claims priority of provisional application 60/332493, filed on Nov. 09, 2001. |
Claims priority of provisional application 60/277440, filed on Mar. 20, 2001. |
Claims priority of provisional application 60/277431, filed on Mar. 20, 2001. |
Claims priority of provisional application 60/277425, filed on Mar. 20, 2001. |
Prior Publication US 2004/0219635 A1, Nov. 04, 2004 |
Int. Cl. C12Q 1/18 (2006.01); C12P 21/06 (2006.01); C12N 1/20 (2006.01); C12N 15/74 (2006.01); C07H 21/04 (2006.01)
|